Condition: Sarcoma · Sponsor: Institut Bergonié
The BCB SARCOMES database is a clinical and biological national database dedicated to sarcoma that contains 3 main databases with specific aims: the first is the pathology database (French expert network dedicated to the management of bone sarcomas \[RESOS\] / French expert network dedicated to the pathology of sarcomas \[RREPS\]), dedicated to systematic review of mesenchymal tumor diagnostics nationwide; the second is clinical (RESOS / French expert clinical network for sarcomas \[NETSARC\]), collecting multidisciplinary tumor boards (MDTB) data of patients nationwide, and the third (CONTICABASE / BONE / GIST) is dedicated to collecting patients longitudinal/follow up data, with a focus on treatments of every events, and a catalogue of associated samples. Primary objectives of BCB-SARCOMES are the following: description of the patterns of care and treatment outcomes, assessment of the prognostic factors of patients' outcomes. With the financial support of the French National Cancer Institute \[Institut National du cancer \[INCa\]).
This description comes directly from the study's public registry record.
Maud Toulmonde, MD · 0556333333 · m.toulmonde@bordeaux.unicancer.fr
Simone Mathoulin-Pélissier, MD/PhD · 05563333 · s.mathoulin@bordeaux.unicancer.fr
Always discuss trial participation with your own doctor first.
| Institut Bergonié, Comprehensive Cancer Center | Bordeaux, France | Recruiting |
| Centre Léon Bérard | Lyon, France | Recruiting |
| Institut Gustave Roussy, Comprehensive Cancer Center | Villejuif, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03978039